CA:DRUG / Bright Minds Biosciences Inc. - Net Long/Short Value

Bright Minds Biosciences Inc.
CA ˙ CNSX ˙ CA10919W4056
CA:DRUG / Bright Minds Biosciences Inc. - Net Long/Short Value
Den här sidan ger nettovärderingarna långa/korta för varje institutionellt innehav som rapporterats via 13F- eller NPORT-anmälningar. För att beräkna nettolångt/kortt värde adderar vi aktievärdet till köpoptionsvärdet och subtraherar säljoptionsvärdet. Fonder som rapporterar kortlånade positioner kommer att rapportera aktievärden som negativa. Långa nettopositioner kommer att ha positiva siffror i kolumnen netto lång/kort, och korta nettopositioner kommer att ha negativa värden i den kolumnen.
Ägare Eget kapitalvärde
($1000)
Call värde
($1000)
Put värde
($1000)
Net Long/Short
($1000)
Global Retirement Partners, LLC
Bell Investment Advisors, Inc
Vanguard Fiduciary Trust Co
Sterling Capital Management LLC
Balyasny Asset Management Llc
Walleye Capital LLC
BlackRock, Inc.
Wellington Management Group Llp
Woodline Partners LP
Parkman Healthcare Partners LLC
SBI Securities Co., Ltd.
Seven Fleet Capital Management LP
Millennium Management Llc
Strs Ohio
New York State Common Retirement Fund
State Board Of Administration Of Florida Retirement System
Bank Of America Corp /de/
California State Teachers Retirement System
Deerfield Management Company, L.p. (series C)
Wells Fargo & Company/mn
Vestal Point Capital, LP
Tower Research Capital LLC (TRC)
GAMMA Investing LLC
Perceptive Advisors Llc
Driehaus Capital Management Llc
Nuveen, LLC
Persistent Asset Partners Ltd
Platinum Investment Management Ltd
Twin Peaks Wealth Advisors, LLC
State Street Corp
Ghisallo Capital Management LLC
Vanguard Group Inc
MAI Capital Management
Eventide Asset Management, Llc
Bnp Paribas Arbitrage, Sa
Acuta Capital Partners, Llc
Cwm, Llc
Police & Firemen's Retirement System of New Jersey
Schonfeld Strategic Advisors LLC
UBS Group AG
Ra Capital Management, L.p.
Sio Capital Management, LLC
Rhumbline Advisers
Superstring Capital Management Lp
D. E. Shaw & Co., Inc.
Susquehanna International Group, Llp
Ameritas Investment Partners, Inc.
Barclays Plc
Great Point Partners Llc
Vanguard Portfolio Management Llc
Janus Henderson Group Plc
Adage Capital Partners Gp, L.l.c.
ADAR1 Capital Management, LLC
Virtu Financial LLC
Boothbay Fund Management, Llc
Aquatic Capital Management LLC
Morgan Stanley
Goldman Sachs Group Inc
AdvisorShares Investments LLC
Quadrature Capital Ltd
Jpmorgan Chase & Co
Ameriprise Financial Inc
Braidwell Lp
Russell Investments Group, Ltd.
China Universal Asset Management Co., Ltd.
Orbimed Advisors Llc
Cormorant Asset Management, LP
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.
Charles Schwab Investment Management Inc
LPL Financial LLC
Royal Bank Of Canada
Fmr Llc
Allworth Financial LP
Invesco Ltd.
Vivo Capital, LLC
Trexquant Investment LP
Vanguard Global Advisers, LLC
B Group, Inc.
Price T Rowe Associates Inc /md/
Northern Trust Corp
Seven Grand Managers, Llc
EAM Investors, LLC
Jane Street Group, Llc
KVP Capital Advisors, LP
Citigroup Inc
Legal & General Group Plc
Artia Global Partners LP
Ikarian Capital, LLC
Geode Capital Management, Llc
DnB Asset Management AS
Deutsche Bank Ag\
MPM Oncology Impact Management LP
Bank of New York Mellon Corp
MetLife Investment Management, LLC
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
US:DRUG 68,70 US$
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista